TRANEXAMIC Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tranexamic, and when can generic versions of Tranexamic launch?
Tranexamic is a drug marketed by Am Regent, Amneal Pharms Co, Apotex, Avet Lifesciences, Caplin, Chartwell Rx, Epic Pharma Llc, Eugia Pharma, Fresenius Kabi Usa, Gland, Heritage, Micro Labs, Milla Pharms, Mylan Institutional, Rising, Xgen Pharms, Zydus Pharms, Amneal, Exela Pharma, Nexus, Actavis Labs Fl Inc, Ani Pharms, Appco, Aurobindo Pharma Usa, Bionpharma, I 3 Pharms, and Rubicon Research. and is included in thirty-two NDAs.
The generic ingredient in TRANEXAMIC is tranexamic acid. There are eight drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the tranexamic acid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tranexamic
A generic version of TRANEXAMIC was approved as tranexamic acid by AM REGENT on August 10th, 2011.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TRANEXAMIC?
- What are the global sales for TRANEXAMIC?
- What is Average Wholesale Price for TRANEXAMIC?
Summary for TRANEXAMIC
| US Patents: | 0 |
| Applicants: | 27 |
| NDAs: | 32 |
| Drug Prices: | Drug price information for TRANEXAMIC |
| DailyMed Link: | TRANEXAMIC at DailyMed |
US Patents and Regulatory Information for TRANEXAMIC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rubicon Research | TRANEXAMIC ACID | tranexamic acid | TABLET;ORAL | 218320-001 | Jun 11, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Appco | TRANEXAMIC ACID | tranexamic acid | TABLET;ORAL | 218729-001 | Jun 11, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Aurobindo Pharma Usa | TRANEXAMIC ACID | tranexamic acid | TABLET;ORAL | 205133-001 | Sep 21, 2015 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Am Regent | TRANEXAMIC ACID | tranexamic acid | INJECTABLE;INJECTION | 201885-001 | Aug 10, 2011 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Zydus Pharms | TRANEXAMIC ACID | tranexamic acid | INJECTABLE;INJECTION | 205228-001 | Jul 17, 2017 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Nexus | TRANEXAMIC ACID | tranexamic acid | SOLUTION;INTRAVENOUS | 216877-001 | Apr 16, 2024 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
